Health Condition 1: C539- Malignant neoplasm of cervix uteri, unspecified
Conditions
Interventions
Intervention1: NIL: NIL
Sponsors
University College of Medical Sciences
Eligibility
Inclusion criteria
Inclusion criteria: Patients who are pathologically confirmed as gynaecological cancers receiving multiple cycle of chemotherapy of any type at DSCI, Delhi and patients willing to participate in the study.
Exclusion criteria
Exclusion criteria: Patients with history of diabetes mellitus, diabetic peripheral neuropathy Patients with history of thyroid disorders Ptients with history of alcohol abuse patients with history of focal neuropathy such as carpel tunnel syndrome patients with history of chemotherapy for other malignancy other tha gynaecological cancers
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess and evaluate the proportion of gynaecological cancer patients experiencing neuropathic pain component in CIPN by utilizing DN4 Questionnaire Score NPSI Questionnaire Score NRS numbness Score and NRS weakness Score.Timepoint: at 3 months after the last cycle of chemotherapy | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess & evaluate the impact of CIPN on quality of life in gynecological cancer patients using Short Form Health Survey 12 questionnaire score To assess & evaluate the co-relation between DN4and SF-12 & relevant NPSI(Neuropathic Pain Symptom Inventory) & SF-12. To assess & evaluate the co-relation between NRS-numbness Score & SF-12 & NRS weakness Score & SF-12.Timepoint: at 3 months after the last cycle of chemotherapy | — |
Countries
India
Contacts
Public ContactDr Deepanshu
UCMS and GTB Hospital
Outcome results
None listed